Minerva Neurosciences (NASDAQ: NERV) COO holds 20,872 shares, 750K and 680K options
Rhea-AI Filing Summary
Minerva Neurosciences, Inc. (ticker NERV) reported initial insider holdings for Chief Operating Officer Joseph H. Reilly. He directly owns 20,872 shares of common stock. He also holds several employee stock options on common stock at exercise prices between $2.12 and $28.00 per share with expirations from 2030 through 2036.
Two option grants with exercise prices of $28.00 and $6.33 are noted as fully vested. Other grants follow time-based vesting schedules that begin between 2023 and 2027, typically vesting 25% on a specified date and then in equal quarterly installments over three years.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Reilly Joseph H.
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F2 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F3 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F4 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F5 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F6 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 1,593,725 shares (Direct);
Common Stock — 20,872 shares (Direct)
Footnotes (6)
- F1. Fully vested.
- F2. The option vested 25% on December 13, 2023 and then vests or vested in equal quarterly installments over 3 years thereafter.
- F3. The option vested 25% on October 4, 2024 and then vests or vested in equal quarterly installments over 3 years thereafter.
- F4. The option vested 25% on December 5, 2025 and then vests or vested in equal quarterly installments over 3 years thereafter.
- F5. The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter.
- F6. The option vests 25% on June 3, 2027 and then in equal quarterly installments over 3 years thereafter.
Key Figures
Direct common shares held: 20,872 shares
Option exercise price: $28.00 per share
Underlying shares at $28.00: 10,625 shares
+5 more
8 metrics
Direct common shares held
20,872 shares
Direct ownership of Minerva Neurosciences, Inc. common stock by Joseph H. Reilly
Option exercise price
$28.00 per share
Employee stock option on 10,625 underlying common shares expiring October 12, 2030
Underlying shares at $28.00
10,625 shares
Underlying common shares for option with $28.00 exercise price
Largest option underlying shares
750,000 shares
Underlying common shares for option with $3.98 exercise price expiring December 21, 2035
Second-largest option underlying shares
680,000 shares
Underlying common shares for option with $4.68 exercise price expiring June 2, 2036
Option exercise price
$2.12 per share
Employee stock option on 47,500 underlying common shares expiring December 4, 2034
First vesting date for 750,000-share option
December 22, 2026
25% vests on this date, then in equal quarterly installments over 3 years
First vesting date for 680,000-share option
June 3, 2027
25% vests on this date, then in equal quarterly installments over 3 years
Key Terms
Employee Stock Option (right to buy), underlying security, vests or vested in equal quarterly installments, fully vested
4 terms
Employee Stock Option (right to buy) financial
"security_title: Employee Stock Option (right to buy)"
underlying security financial
"underlying_security_title: Common Stock"
vests or vested in equal quarterly installments financial
"then vests or vested in equal quarterly installments over 3 years thereafter"
fully vested financial
"Footnote F1 states: Fully vested."
FAQ
What does the Form 3 for NERV disclose about Joseph H. Reilly?
The Form 3 shows that Minerva Neurosciences COO Joseph H. Reilly directly holds 20,872 common shares and multiple employee stock options on common stock with exercise prices from $2.12 to $28.00 per share, expiring between 2030 and 2036.
What stock options on NERV does Joseph H. Reilly hold and at what exercise prices?
He holds several employee stock options on NERV common stock, including options with exercise prices of $28.00, $6.33, $3.11, $6.41, $2.12, $3.98, and $4.68 per share, each with different expiration dates from 2030 to 2036.
Which of Joseph H. Reilly’s NERV options are already fully vested?
Options with exercise prices of $28.00 and $6.33 per share are described as fully vested. Other option grants vest 25% on specified dates starting between 2023 and 2027, then in equal quarterly installments over three years.
What are the vesting terms for Joseph H. Reilly’s more recent NERV option grants?
One grant for 750,000 underlying shares at $3.98 per share vests 25% on December 22, 2026 then quarterly over three years. Another for 680,000 underlying shares at $4.68 per share vests 25% on June 3, 2027 then quarterly over three years.
AI-generated analysis. How Rhea-AI works. Not financial advice.
